Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of April 2021, with a report date of April 15, 2021. The document serves as a transaction notification regarding insider trading activities by Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs) with the company.
Key Financial Metrics
The filing does not contain corporate financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It exclusively details specific share acquisition transactions.
| Transaction Type | Instrument | Price per Share | Total Volume (Shares) |
|---|---|---|---|
| Acquisition (Dividend Re-investment) | Ordinary Shares (25p each) | £12.9508 | 23,999.668 |
Note: Total volume is the aggregate of 13 individual transactions listed in the filing.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document records routine acquisitions of ordinary shares by executives and their associates following the re-investment of dividends paid on April 8, 2021. All transactions were executed on April 13, 2021, on the London Stock Exchange (XLON).
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a statutory disclosure of specific share transactions.
Key Facts for Investor Verification
- Transaction Nature: All reported transactions were acquisitions of ordinary shares resulting from dividend re-investment plans, not open market purchases or sales.
- Participants: Transactions involved 13 individuals, including the CEO (Ms. E. Walmsley), Presidents of Global Vaccines and Global Pharmaceuticals, and other senior executives.
- Execution Details: All trades occurred on a single date (April 13, 2021) at a uniform price of £12.9508 per share.
- Financial Data: This filing does not provide quarterly or annual financial results; investors should refer to Form 20-F or earnings releases for performance metrics.